Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lawyer Urges China To Launch Own Probe Of Pfizer Bribery Allegations

This article was originally published in PharmAsia News

Executive Summary

A Beijing lawyer has urged Chinese authorities to conduct their own investigation of Pfizer's alleged bribes of regulators and medical workers in China.

A Beijing lawyer has urged Chinese authorities to conduct their own investigation of Pfizer's alleged bribes of regulators and medical workers in China. The lawyer asked the Supreme People's Procuratorate to look into the matter in the wake of the U.S. company's $15 million settlement with its government covering allegations it and its subsidiaries made improper payments in eight countries, including China. The settlement was based on a U.S. Securities and Exchange Commission complaint of such payments as far back as 2001, which Pfizer neither denied nor admitted. Payments in question also were said to have been made in Indonesia and Pakistan. (Click here for more)

"Pfizer Facing Possible Fines Over Bribery Claim" - China Daily (8/16/2012)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC081906

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel